CHD prevention: the importance of identifying dyslipidaemia.

about

CHD prevention: the importance of identifying dyslipidaemia.

Item

http://www.wikidata.org/entity/Q44595763

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

CHD prevention: the importance of identifying dyslipidaemia.

@en

CHD prevention: the importance of identifying dyslipidaemia.

@nl

type

Item

label

CHD prevention: the importance of identifying dyslipidaemia.

@en

CHD prevention: the importance of identifying dyslipidaemia.

@nl

prefLabel

CHD prevention: the importance of identifying dyslipidaemia.

@en

CHD prevention: the importance of identifying dyslipidaemia.

@nl

P1476

CHD prevention: the importance of identifying dyslipidaemia.

@en

P2093

Julie Foxton

http://www.w3.org/2001/XMLSchema#string

P2860

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF).

Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease.

P304

950-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12968/BJON.2003.12.16.11440

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14508418

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias